Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Weekly vs Monthly Tafenoquine in Healthy Vietnamese
NCT05203744Phase 4Unknown
- Sponsor
- Naval Medical Research Command
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tafenoquine in malaria, sponsored by Naval Medical Research Command. Status: unknown.
02
Drugs
tafenoquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT05203744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05203744.